查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954692

牙科生物再生材料市场规模、占有率、成长及全球产业分析：依产品类型、形态、最终用户和地区划分的洞察与预测（2026-2034年）

Dental Orthobiologics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 请询问到货日

价格

牙科生物再生材料市场成长驱动因素

全球牙科生物再生材料市场规模在2025年达到 10.19亿美元，预计从2026年的10.4806亿美元成长至2034年的16.1259亿美元，在预测期（2026-2034年）内年复合成长率为 5.50%。2025年，北美市场占据主导地位，市场占有率高达48.73%，这主要得益于对牙科植体的高需求和强劲的产品创新。

牙科生物再生材料包括天然和合成材料，目的是促进牙科治疗中骨骼、软骨和软组织的再生。这些产品包括同种异体移植材料、合成骨移植替代物、脱矿骨基质、细胞同种异体移植材料、骨生长因子以及其他用于牙科种植、牙周再生和颚骨重建等手术的生物製剂。

市场动态

由于无牙症、牙周病和齿槽骨吸收等牙科疾病的增加，市场扩张。这些疾病通常需要进行骨移植和再生治疗，这推动了对生物衍生再生材料的需求。根据世界卫生组织的资料，口腔疾病影响全球数十亿人，无牙颌的盛行率显着上升，尤其是在老龄化社会。

2020年，因新冠疫情导致牙医诊所限制营业，市场收入暂时下降。然而，随着诊所重新开放以及植牙手术和骨移植手术的普及，市场在2021年开始復苏。远距牙科和数位化治疗计划的日益普及进一步推动了手术量的成长。

主要市场趋势

影响牙科生物再生材料市场的主要趋势之一是植牙手术的快速成长。当天然骨量不足时，骨移植替代材料广泛用于增加颚骨体积并确保植体的稳定性。种植技术的进步增加了手术的复杂性，进一步推动了对先进再生材料的需求。

另一个新兴趋势是合成和3D列印骨移植替代材料的日益普及。这些产品相比传统移植材料具有许多优势，例如更高的生物相容性、可预测的再生效果以及成本效益。生物再生材料的创新正为复杂的牙科手术提供更个人化的解决方案。

成长因素

牙骨疾病的日益普遍是推动市场成长的主要因素。牙周病、牙齿脱落和下颚骨萎缩都需要使用生物再生材料进行再生治疗。临床医师对先进再生解决方案的认识不断提高，也加速了这些解决方案的普及应用。

此外，合成骨替代材料的广泛应用也推动了市场成长。这些材料具有优异的骨传导性能，同时降低了免疫反应和疾病传播的风险。价格优势和易得性进一步推动了它们在新兴市场的普及应用。

产业参与者之间的策略性收购和联盟也有助于加强产品组合併拓展全球分销网路。

限制因子

儘管具有成长潜力，但临床限制可能会阻碍市场扩张。一些生物来源的再生材料与不良组织反应、骨形成不完全和免疫原性风险有关。与骨形态发生蛋白和异种移植相关的发炎和移植物移位等併发症可能会阻碍其应用。

此外，对机械强度、吸收率和手术时长的担忧可能会影响临床医生的选择和患者的治疗结果，对市场成长构成挑战。

市场区隔分析

依产品类型

预计到2026年，骨生长因子细分市场将占据主导地位，市场占有率达到41.31%，这主要得益于需要高级骨再生技术的牙科植牙手术数量的增加。由于其生物相容性、低製造成本和不断扩大的出口合作关係，合成骨移植替代物预计将以更高的年复合成长率成长。

依剂型

预计2026年，糊剂型骨生长因子市场占有率将达到45.35%，主要得益于强大的研发投入和糊剂型骨生长因子的广泛应用。颗粒剂型骨生长因子市场占有率预计将以更高的年复合成长率成长，这主要归功于其优异的成骨细胞附着能力和新产品上市数量的增加。

依最终使用者

预计到2026年，私人诊所市场占有率将达到60.49%，这主要得益于数量众多的独立牙科诊所和患者对私人诊所骨生长因子的高偏好。由于整合趋势和手术量增加，预计牙科服务机构/集团诊所将经历更快的成长。

区域洞察

到2025年，北美市场规模达到 4.8737亿美元，凭藉其先进的医疗保健基础设施和频繁的新产品发布，将保持领先地位。

欧洲市场规模位居第二，这得益于 Institut Straumann AG 和 Geistlich Pharma AG 等领导企业的支持。

由于牙科疾病盛行率上升、医疗保健支出增加以及日本、中国和印度等国家对先进产品的日益普及，预计亚太地区将以最高的年复合成长率成长。

由于人们健康意识的提高和医疗保健投资的增加，预计拉丁美洲以及中东和非洲市场将保持稳定成长。

主要公司

主要公司包括 ZimVie Inc.、Institut Straumann AG、Envista、Dentsply Sirona、Henry Schein、Medtronic、BioHorizons、NovaBone 和 Geistlich Pharma AG。策略性收购、产品发布和地理扩张在维持竞争优势方面发挥核心作用。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家和地区牙科疾病盛行率（2025年）
  • 主要产业趋势：併购、合作等
  • 主要公司新产品发布
  • 新冠疫情对市场的影响

第5章 全球牙科生物再生材料市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 同种异体移植
    • 骨生长因子
    • 合成骨移植替代物
    • 去矿物质骨基质
    • 细胞同种异体移植
    • 其他
  • 市场分析、洞察与预测：依类型划分
    • 糊膏
    • 颗粒
    • 油灰
    • 其他
  • 市场分析、洞察与预测：依最终用户划分
    • 私人诊所
    • 牙科服务机构/集团诊所
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北部美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美牙科生物再生材料市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲牙科生物再生材料市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 北欧国家
    • 欧洲其他地区

第8章 亚太地区牙科市场生物再生材料市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 韩国
    • 亚太其他地区

第9章 拉丁美洲牙科生物再生材料市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第10章 中东与非洲牙科生物材料市场分析、洞察与预测（2021-2034）

  • 依国家/地区
    • GCC国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025）
  • 公司简介
    • ZimVie Inc.
    • Institut Straumann AG
    • Envista
    • Dentsply Sirona.
    • Henry Schein, Inc.
    • Medtronic
    • BioHorizons
    • NovaBone（Halma）
    • Geistlich Pharma AG
Product Code: FBI110353

Growth Factors of dental orthobiologics Market

The global dental orthobiologics market size was valued at USD 1,000.19 million in 2025 and is projected to grow from USD 1,048.06 million in 2026 to USD 1,612.59 million by 2034, exhibiting a CAGR of 5.50% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for a 48.73% share, driven by high dental implant volumes and strong product innovation.

Dental orthobiologics include natural and synthetic materials designed to promote bone, cartilage, and soft tissue regeneration in dental applications. These products comprise allografts, synthetic bone graft substitutes, demineralized bone matrix, cellular allografts, bone growth factors, and other biologics used in procedures such as dental implants, periodontal regeneration, and jawbone reconstruction.

Market Dynamics

The market is expanding due to the increasing prevalence of dental disorders such as edentulism, periodontal disease, and alveolar bone loss. These conditions frequently require bone grafting and regenerative procedures, thereby driving demand for orthobiologic materials. According to global health reports, oral diseases affect billions of people worldwide, with edentulism showing significant prevalence among aging populations.

The COVID-19 pandemic temporarily reduced market revenues in 2020 as dental clinics restricted services. However, recovery began in 2021 with the reopening of clinics and increased adoption of implant surgeries and bone grafting procedures. The growing use of tele-dentistry and digital treatment planning further supported procedural volumes.

Key Market Trends

A significant trend shaping the dental orthobiologics market is the rapid increase in dental implant procedures. Bone graft substitutes are widely used to enhance jawbone volume and ensure implant stability when natural bone is insufficient. Technological advancements in implantology have increased procedural complexity, further boosting the need for advanced regenerative materials.

Another emerging trend is the growing adoption of synthetic and 3D-printed bone graft substitutes. These products offer improved biocompatibility, predictable regeneration outcomes, and cost efficiency compared to traditional grafts. Innovations in biomaterials are enabling more customized solutions for complex dental surgeries.

Growth Drivers

The rising prevalence of dental bone disorders is a primary growth driver. Periodontal disease, tooth loss, and jawbone atrophy require regenerative procedures supported by orthobiologic materials. Increasing awareness among clinicians about advanced regenerative solutions is also accelerating adoption.

Additionally, the growing use of synthetic bone substitutes is fueling market growth. These materials reduce the risk of immune reactions and disease transmission while offering improved osteoconductive properties. Their affordability and ease of availability further enhance adoption across emerging markets.

Strategic acquisitions and collaborations among industry players are also strengthening product portfolios and expanding global distribution networks.

Restraining Factors

Despite growth potential, clinical limitations may restrict market expansion. Some orthobiologic products are associated with adverse tissue reactions, incomplete bone formation, and immunogenic risks. Complications related to bone morphogenetic proteins and xenografts, such as inflammation or graft displacement, may hinder adoption.

Furthermore, concerns regarding mechanical strength, resorption rates, and long surgical times can affect clinician preference and patient outcomes, posing challenges to market growth.

Market Segmentation Analysis

By Product Type

The bone growth factors segment dominated with a 41.31% share in 2026, driven by rising dental implant procedures that require enhanced bone regeneration. Synthetic bone graft substitutes are expected to grow at a higher CAGR due to their biocompatibility, lower production costs, and increasing export collaborations.

By Form

The paste segment held 45.35% of the market share in 2026, supported by strong R&D focus and widespread use of bone growth factors in paste form. The granules segment is projected to grow at a higher CAGR due to superior osteoblast attachment and increasing product launches.

By End-user

The solo practices segment accounted for 60.49% share in 2026, owing to a large number of independent dental clinics and high patient preference. DSO/group practices are anticipated to grow at a faster rate due to consolidation trends and rising procedural volumes.

Regional Insights

North America generated USD 487.37 million in 2025, maintaining its leadership due to advanced healthcare infrastructure and frequent product launches.

Europe represents the second-largest market, supported by strong players such as Institut Straumann AG and Geistlich Pharma AG.

Asia Pacific is projected to grow at the highest CAGR, driven by rising dental disease prevalence, increasing healthcare spending, and growing penetration of advanced products in Japan, China, and India.

Latin America and the Middle East & Africa are expected to witness steady growth due to rising awareness and healthcare investments.

Key Industry Players

Leading companies include ZimVie Inc., Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, Medtronic, BioHorizons, NovaBone, and Geistlich Pharma AG. Strategic acquisitions, product launches, and geographic expansions are central to maintaining competitive advantage.

Conclusion

The global dental orthobiologics market is set for steady expansion, increasing from USD 1,000.19 million in 2025 to USD 1,612.59 million by 2034, at a CAGR of 5.50%. Growth is driven by rising dental implant procedures, increasing prevalence of bone disorders, and advancements in synthetic graft technologies. Although clinical limitations pose challenges, continuous innovation, strategic collaborations, and expanding dental care infrastructure are expected to sustain long-term market growth worldwide.

Segmentation By Product Type

  • Allograft
  • Synthetic Bone Graft Substitutes
  • Demineralized Bone Matrix
  • Cellular Allografts
  • Bone Growth Factors
  • Others

By Form

  • Paste
  • Granules
  • Putty
  • Others

By End-user

  • Solo Practices
  • DSO/ Group Practices
  • Others

North America (By Product Type, Form, End-user, Country)

    • U.S.
    • Canada
  • Europe (By Product Type, Form, End-user, Country/ Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Form, End-user, Country/ Sub-region)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Form, End-user, Country/ Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Form, End-user, Country/ Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Dental Disorders, By Key Countries/ Region, 2025
  • 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.3. New Product Launches, By Key Players
  • 4.4. Impact of COVID-19 on the Market

5. Global Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Allograft
    • 5.1.2. Bone Growth Factors
    • 5.1.3. Synthetic Bone Graft Substitute
    • 5.1.4. Demineralized Bone Matrix
    • 5.1.5. Cellular Allografts
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By Form
    • 5.2.1. Paste
    • 5.2.2. Granules
    • 5.2.3. Putty
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Solo Practices
    • 5.3.2. DSO/Group Practices
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Allograft
    • 6.1.2. Bone Growth Factors
    • 6.1.3. Synthetic Bone Graft Substitute
    • 6.1.4. Demineralized Bone Matrix
    • 6.1.5. Cellular Allografts
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By Form
    • 6.2.1. Paste
    • 6.2.2. Granules
    • 6.2.3. Putty
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Solo Practices
    • 6.3.2. DSO/Group Practices
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Allograft
    • 7.1.2. Bone Growth Factors
    • 7.1.3. Synthetic Bone Graft Substitute
    • 7.1.4. Demineralized Bone Matrix
    • 7.1.5. Cellular Allografts
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By Form
    • 7.2.1. Paste
    • 7.2.2. Granules
    • 7.2.3. Putty
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Solo Practices
    • 7.3.2. DSO/Group Practices
    • 7.3.3. Others

8. Market Analysis, Insights and Forecast - By Country/ Sub-Region

  • 8.1.
    • 8.1.1. U.K.
    • 8.1.2. Germany
    • 8.1.3. France
    • 8.1.4. Spain
    • 8.1.5. Italy
    • 8.1.6. Scandinavia
    • 8.1.7. Rest of Europe

9. Asia Pacific Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Allograft
    • 9.1.2. Bone Growth Factors
    • 9.1.3. Synthetic Bone Graft Substitute
    • 9.1.4. Demineralized Bone Matrix
    • 9.1.5. Cellular Allografts
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By Form
    • 9.2.1. Paste
    • 9.2.2. Granules
    • 9.2.3. Putty
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Solo Practices
    • 9.3.2. DSO/Group Practices
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. Southeast Asia
    • 9.4.6. South Korea
    • 9.4.7. Rest of Asia Pacific

10. Latin America Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Allograft
    • 10.1.2. Bone Growth Factors
    • 10.1.3. Synthetic Bone Graft Substitute
    • 10.1.4. Demineralized Bone Matrix
    • 10.1.5. Cellular Allografts
    • 10.1.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By Form
    • 10.2.1. Paste
    • 10.2.2. Granules
    • 10.2.3. Putty
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Solo Practices
    • 10.3.2. DSO/Group Practices
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America

11. Middle East & Africa Dental Orthobiologics Market Analysis, Insights and Forecast, 2021-2034

  • 11.1. Market Analysis, Insights and Forecast - By Product Type
    • 11.1.1. Allograft
    • 11.1.2. Bone Growth Factors
    • 11.1.3. Synthetic Bone Graft Substitute
    • 11.1.4. Demineralized Bone Matrix
    • 11.1.5. Cellular Allografts
    • 11.1.6. Others
  • 11.2. Market Analysis, Insights and Forecast - By Form
    • 11.2.1. Paste
    • 11.2.2. Granules
    • 11.2.3. Putty
    • 11.2.4. Others
  • 11.3. Market Analysis, Insights and Forecast - By End-user
    • 11.3.1. Solo Practices
    • 11.3.2. DSO/Group Practices
    • 11.3.3. Others
  • 11.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 11.4.1. GCC
    • 11.4.2. South Africa
    • 11.4.3. Rest of Middle East & Africa

12. Competitive Analysis

  • 12.1. Global Market Share Analysis (2025)
  • 12.2. Company Profiles
    • 12.2.1. ZimVie Inc.
      • 12.2.1.1. Overview
      • 12.2.1.2. Products & services
      • 12.2.1.3. SWOT Analysis
      • 12.2.1.4. Recent Developments
      • 12.2.1.5. Strategies
      • 12.2.1.6. Financials (Based on Availability)
    • 12.2.2. Institut Straumann AG
      • 12.2.2.1. Overview
      • 12.2.2.2. Products & services
      • 12.2.2.3. SWOT Analysis
      • 12.2.2.4. Recent Developments
      • 12.2.2.5. Strategies
      • 12.2.2.6. Financials (Based on Availability)
    • 12.2.3. Envista
      • 12.2.3.1. Overview
      • 12.2.3.2. Products & services
      • 12.2.3.3. SWOT Analysis
      • 12.2.3.4. Recent Developments
      • 12.2.3.5. Strategies
      • 12.2.3.6. Financials (Based on Availability)
    • 12.2.4. Dentsply Sirona.
      • 12.2.4.1. Overview
      • 12.2.4.2. Products & services
      • 12.2.4.3. SWOT Analysis
      • 12.2.4.4. Recent Developments
      • 12.2.4.5. Strategies
      • 12.2.4.6. Financials (Based on Availability)
    • 12.2.5. Henry Schein, Inc.
      • 12.2.5.1. Overview
      • 12.2.5.2. Products & services
      • 12.2.5.3. SWOT Analysis
      • 12.2.5.4. Recent Developments
      • 12.2.5.5. Strategies
      • 12.2.5.6. Financials (Based on Availability)
    • 12.2.6. Medtronic
      • 12.2.6.1. Overview
      • 12.2.6.2. Products & services
      • 12.2.6.3. SWOT Analysis
      • 12.2.6.4. Recent Developments
      • 12.2.6.5. Strategies
      • 12.2.6.6. Financials (Based on Availability)
    • 12.2.7. BioHorizons
      • 12.2.7.1. Overview
      • 12.2.7.2. Products & services
      • 12.2.7.3. SWOT Analysis
      • 12.2.7.4. Recent Developments
      • 12.2.7.5. Strategies
      • 12.2.7.6. Financials (Based on Availability)
    • 12.2.8. NovaBone (Halma)
      • 12.2.8.1. Overview
      • 12.2.8.2. Products & services
      • 12.2.8.3. SWOT Analysis
      • 12.2.8.4. Recent Developments
      • 12.2.8.5. Strategies
      • 12.2.8.6. Financials (Based on Availability)
    • 12.2.9. Geistlich Pharma AG
      • 12.2.9.1. Overview
      • 12.2.9.2. Products & services
      • 12.2.9.3. SWOT Analysis
      • 12.2.9.4. Recent Developments
      • 12.2.9.5. Strategies
      • 12.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 3: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 4: Global Dental Orthobiologics Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 5: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 6: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 7: North America Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 8: North America Dental Orthobiologics Market Revenue (USD million) Forecast, By Country, 2021-2034
  • Table 9: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 10: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 11: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 12: Europe Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 15: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 18: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 19: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 20: Latin America Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 22: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by Form, 2021-2034
  • Table 23: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, by End-user, 2021-2034
  • Table 24: Middle East & Africa Dental Orthobiologics Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Dental Orthobiologics Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Dental Orthobiologics Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Dental Orthobiologics Market Value Share (%), by Form, 2025 & 2034
  • Figure 4: Global Dental Orthobiologics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Dental Orthobiologics Market Value (USD million), by Region, 2025 & 2034
  • Figure 6: North America Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 7: North America Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 9: North America Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 10: North America Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 11: North America Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 12: North America Dental Orthobiologics Market Value (USD million), By Country, 2025 & 2034
  • Figure 13: North America Dental Orthobiologics Market Value Share (%), By Country, 2025
  • Figure 14: Europe Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 15: Europe Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 17: Europe Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 18: Europe Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 19: Europe Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 25: Asia Pacific Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 26: Asia Pacific Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 31: Latin America Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 33: Latin America Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 34: Latin America Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 35: Latin America Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Dental Orthobiologics Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Dental Orthobiologics Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Dental Orthobiologics Market Value (USD million), by Form, 2025 & 2034
  • Figure 41: Middle East & Africa Dental Orthobiologics Market Value Share (%), by Form, 2025
  • Figure 42: Middle East & Africa Dental Orthobiologics Market Value (USD million), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Dental Orthobiologics Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Dental Orthobiologics Market Value (USD million), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Dental Orthobiologics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Dental Orthobiologics Market Share (%), By Company, 2025